2025
February – XLH presented at the 2025 Annual Meeting of the Association of University Technology Managers (AUTM) in Washington, DC, sharing commercialization readiness frameworks and national outcome data from the NIH-funded I-RED program with university technology transfer leaders and research commercialization professionals.
February – XLH completed the second I-RED cohort, graduating eight university-based innovators who advanced their commercialization milestones related to intellectual property protection, licensing, regulatory, reimbursement, financial modeling, and capital raised.
March – Clover Learning, Inc., an XLH 2018 portfolio company founded in Louisville. KY was acquired by Ascend Learning. Nearly 100% bootstrapped, Clover grew into a national leader in online diagnostic imaging education, serving 24,000 monthly users with 600+ training videos and a 96% learner pass rate, and its acquisition marks a significant expansion of its impact across the allied health workforce.
May – XLH released an I-RED participant impact video highlighting the startup teams' transformation from academic investigators to commercialization-ready entrepreneurs, reinforcing the program’s applied education model and measurable translational outcomes.
June – eBlu Solutions, an XLH 2016 portfolio company headquartered in Louisville, KY, was acquired by Frazier Healthcare Partners through its portfolio company Knipper Health. eBlu developed a category-defining platform that automated medical and pharmacy benefit investigations and prior authorizations at the point of care, reducing processing times from weeks to under 60 seconds and supporting a network of more than 15,000 specialty providers nationwide.
June – RxLightning, Inc., an XLH 2020 portfolio company based in New Albany, IN, was acquired after being founded at the outset of the COVID-19 pandemic. The company built an end-to-end digital platform that streamlined specialty medication onboarding, reduced administrative friction, and accelerated therapy initiation, demonstrating scalable impact in specialty pharmacy access and patient enrollment workflows.
August – XLH presented aggregated I-RED outcomes across two cohorts, 10 universities, and 17 participants, reporting $20.46M in total capital raised, a 32% average knowledge gain across core commercialization domains, and measurable increases in patent filings, licensing progress, entity formation, and SBIR/STTR awards.